1. Home
  2. PACB vs VACH Comparison

PACB vs VACH Comparison

Compare PACB & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • VACH
  • Stock Information
  • Founded
  • PACB 2000
  • VACH 2023
  • Country
  • PACB United States
  • VACH United States
  • Employees
  • PACB N/A
  • VACH N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • VACH
  • Sector
  • PACB Industrials
  • VACH
  • Exchange
  • PACB Nasdaq
  • VACH NYSE
  • Market Cap
  • PACB 364.2M
  • VACH 318.5M
  • IPO Year
  • PACB 2010
  • VACH 2024
  • Fundamental
  • Price
  • PACB $1.54
  • VACH $10.12
  • Analyst Decision
  • PACB Buy
  • VACH
  • Analyst Count
  • PACB 13
  • VACH 0
  • Target Price
  • PACB $2.79
  • VACH N/A
  • AVG Volume (30 Days)
  • PACB 14.1M
  • VACH 253.0
  • Earning Date
  • PACB 02-13-2025
  • VACH 01-01-0001
  • Dividend Yield
  • PACB N/A
  • VACH N/A
  • EPS Growth
  • PACB N/A
  • VACH N/A
  • EPS
  • PACB N/A
  • VACH N/A
  • Revenue
  • PACB $154,014,000.00
  • VACH N/A
  • Revenue This Year
  • PACB $22.84
  • VACH N/A
  • Revenue Next Year
  • PACB $30.91
  • VACH N/A
  • P/E Ratio
  • PACB N/A
  • VACH N/A
  • Revenue Growth
  • PACB N/A
  • VACH N/A
  • 52 Week Low
  • PACB $1.16
  • VACH $9.97
  • 52 Week High
  • PACB $6.09
  • VACH $10.25
  • Technical
  • Relative Strength Index (RSI)
  • PACB 45.60
  • VACH N/A
  • Support Level
  • PACB $1.27
  • VACH N/A
  • Resistance Level
  • PACB $2.06
  • VACH N/A
  • Average True Range (ATR)
  • PACB 0.21
  • VACH 0.00
  • MACD
  • PACB 0.03
  • VACH 0.00
  • Stochastic Oscillator
  • PACB 34.18
  • VACH 0.00

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About VACH VOYAGER ACQUISITION CORP.

Voyager Acquisition Corp is a blank check company.

Share on Social Networks: